2000
DOI: 10.1007/bf02524408
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of bis(dialkylaminomethyl)-o- andm-carboranes and study of these compounds as potential preparations for boron neutron capture therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 2 publications
0
2
0
Order By: Relevance
“…BNCT was primarily used for head and neck cancer treatment [27,28], but improvements of the method turned it into a promising therapy for soft tissues, like breast cancer [29], glioblastoma [30], melanomas of the skin, and liver metastases [31]. However, BNCT has limitations, which are the high concentration of thermal neutrons in the order of 10 n/cm 2 and high concentration of boron-10 in the tumor (20–35 μg per 1 g of tissue) [32,33]. These drawbacks can be improved by the immobilization of different boron-rich compounds, such as carboranes, into carriers such as micelles [34], monoclonic antibodies [35], liposomes [36,37], carbon nanotubes [38], gold nanoparticles [39], and magnetic nanostructures [40,41].…”
Section: Introductionmentioning
confidence: 99%
“…BNCT was primarily used for head and neck cancer treatment [27,28], but improvements of the method turned it into a promising therapy for soft tissues, like breast cancer [29], glioblastoma [30], melanomas of the skin, and liver metastases [31]. However, BNCT has limitations, which are the high concentration of thermal neutrons in the order of 10 n/cm 2 and high concentration of boron-10 in the tumor (20–35 μg per 1 g of tissue) [32,33]. These drawbacks can be improved by the immobilization of different boron-rich compounds, such as carboranes, into carriers such as micelles [34], monoclonic antibodies [35], liposomes [36,37], carbon nanotubes [38], gold nanoparticles [39], and magnetic nanostructures [40,41].…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, an important condition for BNCT technology is the achievement of a high concentration of boron carriers in the tumors, for which the design and selection of boron carriers is critical. [ 256 ] Furthermore, increasing drug blood–brain barrier penetration is a major issue in the treatment of brain diseases. Encouragingly, research has found that nanosheets with photothermal effects, such as black phosphorus, can effectively promote drug blood–brain barrier penetration through photothermal effects, and promote the treatment of Alzheimer's disease and depression.…”
Section: Perspectivementioning
confidence: 99%